According to prescribing information and the company's safety disclosures, you should not use GLP-1 medications - or should only do so under specialist supervision - if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, active or recent pancreatitis, severe gastrointestinal disorders that may be worsened by delayed gastric emptying, are pregnant, planning to become pregnant, or breastfeeding, or have severe kidney disease
- Reduced Variability: Compounded medications can vary significantly from one pharmacy to another, leading to inconsistencies in potency and effectiveness
F.et al (2014)
AbouAlfa, Mi Cancer .2026;[Epub] CrossRef Integrating CyTOF with scRNA-seq reveals that Cyclovirobuxine D inhibits HCC progression through hepatic immune microenvironment remodeling Fuqiang Ma, Lele Zhang, Yitao Fan, Ziyi Xu, Yuhua He, Jiachun Sun, Juan Lu, Xinyu Gu Phytomedicine .2026